BioBanking - The Holy Grail of novel drug and diagnostic developments?

J Clin Bioinforma. 2011 May 13;1(1):14. doi: 10.1186/2043-9113-1-14.

Abstract

The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.